PUBLISHER: iData Research Inc. | PRODUCT CODE: 2034905
PUBLISHER: iData Research Inc. | PRODUCT CODE: 2034905
Global Annuloplasty Repair Device Market Report to 2032
The global annuloplasty repair device market was valued at $232 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 2.0%, reaching $266 million by 2032.
This report covers the global market for annuloplasty repair devices, including products used in mitral and tricuspid valve repair procedures.
The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.
Market growth is supported by advances in minimally invasive repair procedures, demographic factors, and rising investment in tricuspid valve repair. However, valve replacement, transcatheter repair alternatives, and the shift from mitral valve repair to replacement continue to limit stronger expansion.
Market Overview
The global annuloplasty repair device market includes devices used to repair the mitral and tricuspid valves. These products help reshape, reinforce, or stabilize the valve annulus so the valve can close more effectively.
Annuloplasty repair devices include rings and bands used during surgical valve repair. These devices are important in cases where the valve can be repaired rather than replaced, allowing patients to retain more natural valve function.
The market is expected to grow modestly through 2032. Demand is supported by aging populations and the continued clinical role of valve repair, but growth is limited by replacement procedures and the rapid development of transcatheter alternatives.
Advances in minimally invasive surgical techniques are supporting continued demand. Innovations that reduce reliance on median sternotomy have enabled some repair procedures to be performed with smaller incisions, less procedural trauma, and faster recovery times. Robotically assisted valve repair techniques at select centers are also reinforcing the role of surgical repair for appropriately selected patients.
Market Drivers
Advancements in Minimally Invasive Repair Procedures
In both valve repair and replacement procedures, a median sternotomy has traditionally been required to access the heart. This approach is highly invasive and can lead to longer recovery times, more pain, and more visible scarring.
Advances in minimally invasive surgical techniques have allowed some repair procedures to be performed without a full median sternotomy. These approaches can reduce pain, scarring, and overall procedural trauma for patients.
Robotically assisted mitral valve repair procedures are also being tested at some medical centers in Europe. Although these procedures are technically demanding, they can improve patient outcomes and help patients return to normal activity sooner than traditional open approaches. These advancements are expected to support growth in the annuloplasty repair device market.
Demographic Factors
Demographic trends are an important driver of annuloplasty repair device demand. Annuloplasty repair procedures are most common among patients over the age of 65.
As the share of the global population over 65 increases, more patients are expected to require heart valve repair procedures. This supports demand for both annuloplasty bands and annuloplasty rings.
Older patients are more likely to develop valve disease and related cardiac conditions that may require treatment. As this patient population grows, procedure volumes are expected to increase, contributing to higher unit sales in the annuloplasty repair device market.
Investment in the Tricuspid Valve
The tricuspid valve repair market has received growing interest from multiple companies in recent years. This reflects broader recognition that tricuspid disease is an important clinical area with room for improved treatment options.
Abbott, for example, has been working on developing a repair device for the tricuspid valve following the success of its mitral valve repair and replacement devices.
This increased focus on tricuspid repair may support greater awareness, product development, and treatment activity over time. As companies invest in this area, the annuloplasty repair device market may benefit from broader clinical attention to both mitral and tricuspid valve repair.
Market Limiters
Valve Replacement
Not all damaged heart valves can be treated with repair devices. In many cases, the valve has deteriorated too far to be repaired, making valve replacement necessary.
This limits the addressable patient population for annuloplasty repair devices. Even when valve repair is preferred, patient anatomy, disease severity, or valve condition may make replacement the more appropriate option.
Because a significant number of patients do not qualify for repair, valve replacement will continue to limit growth in the annuloplasty repair device market.
Alternatives
Transcatheter heart valve repair is a rapidly growing alternative to surgical annuloplasty. Many companies are working to receive regulatory approval for transcatheter mitral and tricuspid valve repair products.
These technologies can offer a less invasive option for patients who may not be ideal candidates for open surgical repair. As adoption grows, transcatheter repair devices are expected to compete more directly with surgical repair products.
As more transcatheter mitral and tricuspid valve repair devices gain approval and physician adoption increases, the surgical heart valve repair market is expected to face pressure. This will limit the growth potential of annuloplasty repair devices over the forecast period.
Shift from Mitral Valve Repair to Replacement
Physician preference has shifted in some cases from mitral valve repair toward mitral valve replacement. This trend was influenced by clinical evidence indicating that mitral valve replacement may provide a more durable correction of mitral regurgitation than repair in certain patients.
The shift toward mitral valve replacement has limited annuloplasty market growth in recent years. Because annuloplasty devices are used in repair procedures, any reduction in repair volumes directly affects unit demand.
This trend is expected to persist through the forecast period, creating continued pressure on the annuloplasty repair device market.
Market Coverage and Data Scope
Markets Covered and Segmentation
The report covers the global annuloplasty repair device market as a dedicated segment within cardiac surgery devices.
Annuloplasty repair devices are used during mitral and tricuspid valve repair procedures. These products help restore valve function by reshaping or stabilizing the valve annulus.
The market includes annuloplasty rings and bands. Rings are often used when more complete annular support is required, while bands may be used in cases where partial support is sufficient or preferred by the surgeon.
The market is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
This segmentation helps manufacturers, investors, and strategy teams understand how surgical repair demand, valve type, physician technique, product design, and competition from replacement and transcatheter repair options are shaping the global annuloplasty repair device market.
Competitive Analysis
Edwards Lifesciences was the leading competitor in the global annuloplasty repair device market in 2025. The company offers a wide range of annuloplasty products, including the Carpentier-Edwards Physio(TM), Carpentier-Edwards Physio II(TM), and Carpentier-McCarthy-Adams IMR ETLOGIX Annuloplasty Ring.
Edwards Lifesciences benefits from a strong product portfolio, established surgeon familiarity, and a dominant market presence. Its position is expected to remain stable throughout the forecast period, even as the company places greater attention on larger and faster-growing cardiac markets.
Medtronic was the second-leading competitor in the global annuloplasty repair device market. The company offers a broad range of annuloplasty products, including both bands and rings. Its portfolio includes the Contour 3D(R), CG Future(R), Duran AnCore(R), Profile 3D(R), Simplici-T(R), Simulus(R), and Tri-Ad(TM) Adams annuloplasty systems.
Since Medtronic has left the ventricular assist device market, it is expected to expand its presence in the annuloplasty segment. This may support continued share stability and further investment in surgical valve repair.
Corcym was the third-leading company in the annuloplasty repair device market. Its portfolio includes the Memo 3D Rechord(TM), Memo 3D(TM), Sovering(TM), Carbomedics Annuloflo(TM), and Carbomedics Annuloflex(TM) annuloplasty systems. Because Corcym has a more limited and focused product line, it is expected to continue investing in the annuloplasty market and gain share over the forecast period.
Technology and Practice Trends
Minimally Invasive Valve Repair
Minimally invasive valve repair is one of the most important practice trends in the annuloplasty repair device market. These approaches reduce reliance on full sternotomy and can support shorter recovery times.
As more centers build experience with less invasive techniques, annuloplasty repair devices may continue to play a role in selected surgical repair procedures.
Robotically Assisted Repair
Robotically assisted mitral valve repair is being tested at select medical centers, including some in Europe. These procedures require advanced technical skill, but they may improve precision and reduce surgical trauma.
If adoption expands, robotic repair could help preserve demand for surgical valve repair devices in appropriate patients.
Mitral Valve Repair
Mitral valve repair remains an important clinical application for annuloplasty devices. Rings and bands are used to correct annular dilation and improve valve closure.
However, the shift toward mitral valve replacement in some patient groups continues to influence the long-term outlook for this segment.
Tricuspid Valve Repair
Interest in tricuspid valve repair is growing as more companies recognize the clinical opportunity. Investment in tricuspid repair may increase product development and physician awareness.
This could support future demand for annuloplasty repair devices used in tricuspid procedures.
Repair Versus Replacement Decision-Making
The choice between repair and replacement remains central to market demand. Repair is preferred when the valve can be preserved, but replacement is necessary when damage is too severe.
This decision-making process directly affects annuloplasty device volumes.
Competition from Transcatheter Repair
Transcatheter mitral and tricuspid valve repair technologies are advancing quickly. These options may reduce demand for surgical annuloplasty devices, especially in patients who are poor candidates for open surgery.
Suppliers in the annuloplasty market must account for this shift as transcatheter alternatives gain regulatory approval and clinical adoption.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
The Global Annuloplasty Repair Device Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand surgical valve repair trends, and support commercial planning in the global annuloplasty repair device market.